Study of HRS-1780 for chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old
- Your kidney function (eGFR) is between 25 and 90, with specific protein levels in urine
- Your blood potassium level is 4.8 mmol/L or lower
- Your blood sugar control (HbA1c) is less than 10.5%
- You do not have uncontrolled high blood pressure, severe liver problems, or certain kidney diseases
- You have not had a stroke, heart attack, or kidney transplant in the last 90 days, and you are not on dialysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new daily pill (called HRS-7535) that may help protect kidney function in people with chronic kidney disease. It works like a natural hormone to help control blood sugar and reduce inflammation, and the researchers want to see if it can slow down kidney damage.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests a new drug called OJR520 to see if it's safe and how the body processes it. It first tests healthy volunteers and then people with chronic kidney disease to understand the drug's effects.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.